Risultati di ricerca
14 ore fa · The reiteration of the Outperform rating and the $1,001.00 price target reflects confidence in Eli Lilly's direction and potential, as observed during the oncology analyst event. Eli Lilly's strategic diversification and financial strength are underscored as fundamental elements in its pursuit of sustained growth. InvestingPro Insights
14 ore fa · Eli Lilly's strategy also appears to avoid adding commercial-stage assets via business development, instead opting for a more internally focused growth model. Eli Lilly's targeted oncology strategies, particularly with SERD and KRASG12C, were recognized as lower-risk compared to competitors' selective approaches.
14 ore fa · Jun. 3, 2024, 03:39 AM. In a report released today, Tim Long from Barclays assigned a Sell rating to Apple ( AAPL – Research Report ), with a price target of $164.00. The company’s shares ...
14 ore fa · Apple si prepara a puntare sull'IA grazie ad accordo con OpenAI. di Ansa 03-06-2024 - 09:07. (ANSA) - ROMA, 03 GIU - Apple si prepara al grande salto nell'Intelligenza artificiale grazie anche ad un accordo con OpenAI che portarà ChatGpt sull'iPhone, rispondendo così alla competizione già aperta da Google e dalla stessa azienda di Sam Altman.
3 ore fa · News Century Therapeutics, Inc. Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting Best financial portal
14 ore fa · Home > US Stocks > Apple, Inc. ( AAPL) $₹. $192.25. +0.96. (+0.5%) . Market is closed - opens 7 PM, 03 Jun 2024. Apple Inc. is a technology company that designs and manufactures consumer electronics and software. They are most well known for the iPhone, iPad, and Mac computers. 8:00 AM 10:00 AM 12:00 PM May 31 2024, 1:00 PM Apple, Inc.: $192.29.
